Catheter ablation of ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy: where are we today? A clinical review
Key result
Catheter ablation for ventricular tachycardia in patients with ischaemic heart disease prevents recurrence of VT and decreases the number of ICD shocks.
Why the study?
Does catheter ablation prevent recurrence of ventricular tachycardia and decrease ICD shocks in patients with ischaemic and non-ischaemic cardiomyopathy?
Population
Patients with ischaemic cardiomyopathy or non-ischaemic cardiomyopathy at risk for sudden cardiac death
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Supports ablation to reduce ICD shocks in ischaemic cardiomyopathy; leaves open role in non-ischaemic disease.
Structured PICO
Does catheter ablation prevent recurrence of ventricular tachycardia and decrease ICD shocks in patients with ischaemic and non-ischaemic cardiomyopathy?
P
Population
Patients with ischaemic cardiomyopathy (ICM) or non-ischaemic cardiomyopathy (NICM) at risk for sudden cardiac death
I
Intervention
Catheter ablation for ventricular tachycardia (VT)
Catheter ablation is an effective strategy to prevent VT recurrence and reduce ICD shocks in patients with ischaemic cardiomyopathy.
Cite This Study
Wißner et al. (2012) conducted a review in Ventricular tachycardia in ischaemic and non-ischaemic cardiomyopathy. Catheter ablation was evaluated. Catheter ablation for ventricular tachycardia in patients with ischaemic heart disease prevents recurrence of VT and decreases the number of ICD shocks.